Home > Drug Search >
  • company_query: Beijing Molike Technology
  •   > 
Drug Filter
Category:
chemistry (17) biology (5)
Status:
Phase Ⅲ (4) Phase Ⅱ (9) Phase Ⅰ (7) IND Filing (2)
Clinical Stage:
Pending (3) Active (12) Discontinued (5)
Bio-Type:
Cell therapy (2) CAR T cell therapy (1) Vaccine (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (2) Alzheimer's disease (AD) (1) Bladder cancer (1) Breast cancer (1) Clostridium difficile-associated diarrhea (CDAD) (1) Cognitive disorders (1) Avian influenza (1) Gastric cancer (1) Haemoglobinopathies (1) Hypercholesterolemia (1) Hyperlipidemia (1) Myelodysplastic syndrome (MDS) (1) Non-Hodgkin’s lymphoma (NHL) (1) Obesity (1) Ovarian cancer (1) Pancreatic cancer (1) Parkinson's disease (PD) (2) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Sedation (1) Urinary tract infections (1) Fallopian tube cancer (1) Diabetic foot ulcers (1) Anesthesia (1) Cervical carcinoma (1) Sickle cell disease (1) Esophageal adenocarcinoma (1) Peritoneum cancer (1) Trypanosomiasis (1) Clostridial infection (1) Plaque psoriasis (1) Liver cancer (1) Immunodeficiency disorders (1) hematological malignancies (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top